Naples, FL., October 21, 2024 – Naples Comprehensive Health (NCH) has been recognized as a Premier Practice for its exceptional expertise in the treatment of patients with severe chronic obstructive pulmonary disease (COPD) and emphysema using the Zephyr® Valve, a revolutionary, minimally invasive device developed by Pulmonx. This designation places NCH among the top Zephyr Valve treating centers in the nation, acknowledging the high level of care provided to patients undergoing this advanced treatment.
The Zephyr Valve treatment is a minimally invasive procedure that is completed in about an hour and is designed to help patients breathe easier without surgery, so the benefits are achieved without many of the risks of traditional surgical options. The valves reduce lung hyperinflation by allowing trapped air to escape while preventing new air from entering the diseased lobe. This allows the healthier parts of the lung to function better and results in patients being able to breathe more easily and experience less shortness of breath.
As a Premier Practice, NCH continues to demonstrate superior outcomes in the use of this groundbreaking technology, improving the quality of life for patients who previously had limited treatment options. The premier Practice designation also reflects NCH’s dedication to innovative treatments and highlights the center’s expertise in managing even the most complex pulmonary cases.
“We are honored to be recognized as a top center for the treatment of COPD and emphysema using the Zephyr Valve,” said Dr. David Lindner, Division Head Pulmonary Critical Care & Sleep Medicine at NCH. “This distinction underscores our commitment to providing cutting-edge, patient-centered care. The Zephyr Valve allows us to offer patients with severe lung disease a non-surgical option that has significantly improved their breathing, daily functioning, and overall well-being.”
For more information on the Zephyr Valve treatment at NCH, please visit https://nchmd.org/services/pulmonary/pulmonx/.
###
